Clinical, inflammatory, and immune differences between COVID-19 patients with and without cancer: A protocol for systematic review and meta-analysis

INTRODUCTION: The World Health Organization announce that novel coronavirus (COVID-19) is pandemic worldwide on March 11, 2020. In this pandemic, cancer patients are prone to become critically ill after being infected with COVID-19 due to special immune conditions, and cannot effectively benefit fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhongyang, Wang, Peipei, Chen, Bailin, Zhang, Zihao, Jiang, Jun, Zhuang, Yulong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647537/
https://www.ncbi.nlm.nih.gov/pubmed/33157948
http://dx.doi.org/10.1097/MD.0000000000023015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647537/
https://www.ncbi.nlm.nih.gov/pubmed/33157948
http://dx.doi.org/10.1097/MD.0000000000023015

Ejemplares similares